NCT07473128 2026-03-16
Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
Pharmacosmos A/S
Phase 3 Not yet recruiting
Pharmacosmos A/S
SCRI Development Innovations, LLC
Fudan University
Tang-Du Hospital
BeiGene
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shandong Cancer Hospital and Institute
Shanghai Pulmonary Hospital, Shanghai, China
Fudan University
Beijing Haidian Hospital
Shandong Cancer Hospital and Institute
National Cancer Institute (NCI)